HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
HPGC Renmintongtai Pharmaceutical Dividend Announcement
• HPGC Renmintongtai Pharmaceutical announced a annually dividend of ¥0.14 per ordinary share which will be made payable on 2024-07-25. Ex dividend date: 2024-07-25
• HPGC Renmintongtai Pharmaceutical annual dividend for 2024 was ¥0.14
• HPGC Renmintongtai Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.88%
• HPGC Renmintongtai Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 60.91%
HPGC Renmintongtai Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-25 | ¥0.14 | annually | 2024-07-25 |
2021-05-27 | ¥0.12 | annually | 2021-05-27 |
2018-04-25 | ¥0.50 | annually | 2018-04-25 |
2017-04-13 | ¥0.50 | annually | 2017-04-13 |
2014-07-11 | ¥0.13 | annually | |
2011-06-14 | ¥0.49 | annually | |
2010-06-28 | ¥0.68 | annually | |
2009-07-02 | ¥0.74 | annually | |
2008-07-02 | ¥0.10 | annually | |
2006-11-09 | ¥2.37 | annually | |
2006-07-11 | ¥0.10 | annually | |
2005-06-06 | ¥0.02 | annually | |
2002-07-02 | ¥0.03 | annually |
HPGC Renmintongtai Pharmaceutical Dividend per year
HPGC Renmintongtai Pharmaceutical Dividend growth
HPGC Renmintongtai Pharmaceutical Dividend Yield
HPGC Renmintongtai Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.88%. Interested in purchasing HPGC Renmintongtai Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
HPGC Renmintongtai Pharmaceutical Financial Ratios
HPGC Renmintongtai Pharmaceutical Dividend FAQ
Other factors to consider when evaluating HPGC Renmintongtai Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy HPGC Renmintongtai Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: HPGC Renmintongtai Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, HPGC Renmintongtai Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, HPGC Renmintongtai Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from HPGC Renmintongtai Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: HPGC Renmintongtai Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, HPGC Renmintongtai Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: HPGC Renmintongtai Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of HPGC Renmintongtai Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review HPGC Renmintongtai Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.